Literature DB >> 7652681

Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head.

S D Leach1, J A Rose, A M Lowy, J E Lee, C Charnsangavej, J L Abbruzzese, R L Katz, D B Evans.   

Abstract

BACKGROUND: Recurrence in the peritoneum occurs in up to 50% of patients after a potentially curative pancreaticoduodenectomy. Previous authors have implicated preoperative fine-needle aspiration (FNA) as a cause of intraperitoneal tumor dissemination, although prior studies of peritoneal cytology findings have largely involved patients with locally advanced disease.
METHODS: A consecutive series of patients referred to our institution between 1991 and 1993 with suspected or biopsy-proven adenocarcinoma of the pancreatic head was studied prospectively. All patients fulfilled criteria for resectability as assessed by computed tomography: no metastatic disease, no encasement of the superior mesenteric or hepatic arteries, and a patent superior mesenteric-portal venous confluence. Peritoneal washings were obtained at the time of staging laparoscopy and/or at subsequent laparotomy. Data regarding peritoneal cytology results, previous FNA, preoperative chemoradiation, eventual resection, pattern of disease recurrence, and survival were collected.
RESULTS: A total of 80 peritoneal washings from 60 consecutive patients were prospectively examined. Forty-nine (82%) of 60 patients underwent FNA before peritoneal washings were obtained. A total of four patients (7%) had positive peritoneal cytology findings: three (6%) of 49 who underwent prior FNA and one (9%) of 11 with no prior FNA. Similarly, no differences in eventual peritoneal failure or short-term survival were observed for patients who underwent prior FNA compared with patients who did not. All four patients with positive peritoneal cytology findings had metastatic disease (liver, three; peritoneum, one) at a median of 4.8 months after diagnosis; three of the four died of disease at a median of 8 months.
CONCLUSIONS: Positive peritoneal cytology findings are rare in patients with radiologically resectable adenocarcinoma of the pancreas. When found, positive peritoneal washings are an indicator of advanced disease characterized by unresectability, early metastasis, and short survival. Computed tomographic-guided FNA does not appear to increase the risk for positive peritoneal washings and represents a valid approach to the pretreatment diagnosis of patients with suspected pancreatic malignancy.

Entities:  

Mesh:

Year:  1995        PMID: 7652681     DOI: 10.1016/s0039-6060(05)80361-7

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  24 in total

Review 1.  [Minimal residual tumor in gastrointestinal carcinoma. Relevance to prognosis and oncologic surgical consequences].

Authors:  S Gretschel; A Bembenek; T Schulze; W Kemmner; P M Schlag
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

2.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 3.  Oncological problems in pancreatic cancer surgery.

Authors:  Akimasa Nakao; Tsutomu Fujii; Hiroyuki Sugimoto; Naohito Kanazumi; Shuji Nomoto; Yasuhiro Kodera; Soichiro Inoue; Shin Takeda
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

4.  Detection of disseminated pancreatic cells by amplification of cytokeratin-19 with quantitative RT-PCR in blood, bone marrow and peritoneal lavage of pancreatic carcinoma patients.

Authors:  Katrin Hoffmann; Christiane Kerner; Wolfgang Wilfert; Marc Mueller; Joachim Thiery; Johann Hauss; Helmut Witzigmann
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

5.  Cytology of peritoneal lavage performed during staging laparoscopy for gastrointestinal malignancies: is it useful?

Authors:  E J Nieveen van Dijkum; P D Sturm; L T de Wit; J Offerhaus; H Obertop; D J Gouma
Journal:  Ann Surg       Date:  1998-12       Impact factor: 12.969

6.  Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique.

Authors:  D B Evans; M L Frazier; C Charnsangavej; R L Katz; L Larry; J L Abbruzzese
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

7.  Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses.

Authors:  M Voss; P Hammel; G Molas; L Palazzo; A Dancour; D O'Toole; B Terris; C Degott; P Bernades; P Ruszniewski
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

8.  Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography.

Authors:  R C Liu; L W Traverso
Journal:  Surg Endosc       Date:  2005-03-23       Impact factor: 4.584

9.  Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases.

Authors:  C J Stewart; P R Mills; R Carter; J O'Donohue; G Fullarton; C W Imrie; W R Murray
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

10.  Postoperative cytology for drained fluid from the pancreatic bed after "curative" resection of pancreatic cancers: does it predict both the patient's prognosis and the site of cancer recurrence?

Authors:  Osamu Ishikawa; Hiroshi Wada; Hiroaki Ohigashi; Yuichiro Doki; Shigekazu Yokoyama; Shingo Noura; Terumasa Yamada; Yo Sasaki; Shingi Imaoka; Tsutomu Kasugai; Takashi Matsunaga; Akemi Takenaka; Akihiko Nakaizumi
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.